Balance Sheet (USD $)	Jul. 31, 2012	Jul. 31, 2011
Current assets
Cash and cash equivalents	$ 20,423	$ 51,789
Total current assets	20,423	51,789
Other assets
Patents and patent applications (net of accumulated amortization)	24,553	25,926
Total assets	44,976	77,715
Liabilities
Accounts payable and accrued liabilities	55,497	104,136
Accrued salaries and wages	56,300	4,127
Due to related party	136,412	307,969
Convertible notes payable (Net of Debt Discounts)	223,693
Derivative liability	191,792
Total liabilities	663,694	416,232
Stockholders' equity (deficit)
Common stock; par value $0.001; 200,000,000 shares authorized; 126,083,416 shares issued and outstanding at July 31, 2012 and 76,976,333 shares issued and outstanding at July 31, 2011	126,083	76,976
Additional paid-in capital	23,184,094	11,092,214
Accumulated deficit during the development stage	(23,928,895)	(11,507,707)
Total stockholders' equity (deficit)	(618,718)	(338,517)
Total liabilities and stockholders' equity(deficit)	$ 44,976	$ 77,715